- December 13, 2025
Loading
WellSpring Pharmaceutical Corp. has attacked a big issue with a small, albeit icky, solution: antifungal foot ointment.
The issue at hand is bilingual marketing for over-the-counter medical products. Few pharmaceutical firms have pulled it off, with regulations and costs two of the biggest hurdles.
“Everyone talks about doing it, but you don't see a whole lot of it done,” says Sean Griffin, director of sales and marketing of consumer brands at Sarasota-based WellSpring. “I figured this will be a good niche for us.”